Christian Jung - Profile and Investment Details

Investor Profile

Christian Jung is a Venture Capital, Private Equity Firm, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Gen2 Neuroscience, Nordic, Alector, LoQus23 Therapeutics Ltd, TRiCares GmbH, Mitoconix Bio, AstronauTxBrainWaveBank, Nitrome Biosciences, Amphista Therapeutics Limited, Leal Therapeutics, coramaze technologies GmbH, Cerevance, QurAlis, Amathus Therapeutics, Transine Therapeutics, Ribometrix, Harness Therapeutics, UroMems, Autifony Therapeutics, Rigontec GmbH, Tiaki Therapeutics, Evelo Biosciences, Caraway Therapeutics, Amal Therapeutics, Therini Bio, WISE S.r.l., . Over time, Christian Jung has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Christian Jung is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Market Research, Neuroscience, Clinical Trials, Health Diagnostics, UK-based Startups, Digital Health, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Christian Jung, as their portfolio suggests a familiarity and interest in this area.

Understanding Christian Jung’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.